Adding Bevacizumab To Single-Agent Chemotherapy For The Treatment Of Platinum-Resistant Recurrent Ovarian Cancer- A Cost-Effectiveness Analysis Of The Aurelia Trial
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1193
https://www.valueinhealthjournal.com/article/S1098-3015(15)03269-6/fulltext
Title :
Adding Bevacizumab To Single-Agent Chemotherapy For The Treatment Of Platinum-Resistant Recurrent Ovarian Cancer- A Cost-Effectiveness Analysis Of The Aurelia Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03269-6&doi=10.1016/j.jval.2015.09.1193
First page :
A461
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
693